Abstract
Asphyxiated neonates often have hypotension, shock and poor tissue perfusion. Various inotropic medications are commonly used to provide the cardiovascular support to improve the blood pressure and to treat shock. However, there is a paucity of literature on the systemic and regional hemodynamic effects of these inotropic medications in asphyxiated neonates, necessitating cautious translation of findings from other clinical populations and animal studies. This review discusses the current available information, from both clinical studies and animal models of neonatal asphyxia, on commonly used mediations including dopamine, dobutamine, epinephrine, milrinone, levosimendan and hydrocortisone.
Keywords: Newborn, asphyxia, inotropes, catecholamines, blood pressure
Current Pediatric Reviews
Title: Inotropic Therapies in Asphyxiated Neonates: The Clinical and Laboratory Facts
Volume: 5 Issue: 2
Author(s): Chloe Joynt and Po-Yin Cheung
Affiliation:
Keywords: Newborn, asphyxia, inotropes, catecholamines, blood pressure
Abstract: Asphyxiated neonates often have hypotension, shock and poor tissue perfusion. Various inotropic medications are commonly used to provide the cardiovascular support to improve the blood pressure and to treat shock. However, there is a paucity of literature on the systemic and regional hemodynamic effects of these inotropic medications in asphyxiated neonates, necessitating cautious translation of findings from other clinical populations and animal studies. This review discusses the current available information, from both clinical studies and animal models of neonatal asphyxia, on commonly used mediations including dopamine, dobutamine, epinephrine, milrinone, levosimendan and hydrocortisone.
Export Options
About this article
Cite this article as:
Joynt Chloe and Cheung Po-Yin, Inotropic Therapies in Asphyxiated Neonates: The Clinical and Laboratory Facts, Current Pediatric Reviews 2009; 5 (2) . https://dx.doi.org/10.2174/157339609788185712
DOI https://dx.doi.org/10.2174/157339609788185712 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Use of N-acetyl-cysteine to Prevent Nephrotoxicity Associated with Iodinated Contrast Agents
Current Drug Therapy The Use of Biomarkers in Sepsis: A Systematic Review
Current Pharmaceutical Biotechnology Application of VEGF Gene Therapy in Two Basic Fields of Plastic- Reparative Surgery: Tissue Reconstruction with Flaps and Peripheral Nerve Surgery
Recent Patents on Regenerative Medicine The Role of Growth Factors in the Prevention and Treatment of Chemotherapy-Induced Peripheral Neurotoxicity
Current Drug Safety Calcium Sensitizers in Cardiac Surgery: Who, When, How and Why?
Current Vascular Pharmacology Analgesic and Anti-Inflammatory Activities of Extracts and Fatty Acids from Celtis australis L
The Natural Products Journal Radix Astragali (Astragalus): Latest Advancements and Trends in Chemistry, Analysis, Pharmacology and Pharmacokinetics
Current Organic Chemistry Diabetes and Nutritional Screening in Post-Bariatric Patients
Current Diabetes Reviews Complement Activation-Related Pseudoallergy Caused by Amphiphilic Drug Carriers: The Role of Lipoproteins
Current Drug Delivery Gender Differences in Pharmacokinetics and Side Effects of Second Generation Antipsychotic Drugs
Current Neuropharmacology Prolonged Exposure to Ketamine Increases Brain Derived Neurotrophic Factor Levels in Developing Rat Brains
Current Drug Safety Sex Steroid Hormones, Cardiovascular Diseases and The Metabolic Syndrome
Cardiovascular & Hematological Agents in Medicinal Chemistry Monoclonal Antibodies in the Treatment of Systemic Lupus Erythematosus
Current Drug Targets Synthesis, Physico-Chemical Properties and DFT Calculations of New 2-(4- Arylpiperazine-1-yl)-1-(3-ethylbenzofuran-2-yl)ethanols As Potential Antihypertensive Agents
Current Organic Chemistry Endogenous Cardioprotective Agents: Role in Pre and Postconditioning
Current Drug Targets New Insights for Multifactorial Disease Therapy: The Challenge of the Symbiotic Drugs
Current Drug Therapy Decreasing Arterial Aging by Controlling Blood Pressure Levels and Hypertension: A Step Forward
Current Vascular Pharmacology The Effect of Polyphenol Consumption on Blood Pressure
Mini-Reviews in Medicinal Chemistry Nutrition and Physical Activity on Hypertension: Implication of Current Evidence and Guidelines
Current Hypertension Reviews Neonatal Hypertension: An Underdiagnosed Condition, A Review Article
Current Hypertension Reviews